THE battle against multiply
resistant organisms is making
some headway with new studies
demonstrating the efficacy of
various combinations thwarting the
development of resistance.
Researchers published in
Australian Prescriber say that while
ceftolozane with tazobactam is
effective, the combination should
probably be reserved for severe
cases where a multidrug resistant
organism is suspected.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jun 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jun 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.